Table 2.
Phenotypes Study 2 |
IML | nNOS | CRH | IML-nNOS | IML-CRH | CRH-nNOS |
---|---|---|---|---|---|---|
N (4) | 200 ± 39 | 449 ± 34 | 1232 ± 33 | 43 ± 8 | 84 ± 14 | 197 ± 12 |
AH (5) | 223 ± 23 | 454 ± 34 | 1100 ± 79 | 41 ± 5 | 93 ± 8 | 156 ± 5* |
Activated Study 2 |
IML-Fos | nNOS-Fos | CRH-Fos | IML-nNOS-Fos | IML-CRH-Fos | CRH-nNOS-Fos |
---|---|---|---|---|---|---|
N (4) | 9 ± 2 | 19 ± 6 | 64 ± 23 | 3 ± 1 | 6 ± 1 | 14 ± 4 |
AH (5) | 10 ± 1 | 77 ± 9* | 167 ± 31* | 3 ± 1 | 7 ± 1 | 38 ± 8* |
AH > N. Abbreviations are described in text.